Persistent Recovery of Normal Left Ventricular Function and Dimension in Idiopathic Dilated Cardiomyopathy During Long‐Term Follow‐up: Does Real Healing Exist?
暂无分享,去创建一个
A. di Lenarda | G. Barbati | G. Sinagra | A. Lenarda | M. Merlo | B. Pinamonti | F. Negri | D. Stolfo | M. Anzini | F. Ramani | A. Di Lenarda
[1] A. Kadish,et al. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. , 2014, Journal of the American College of Cardiology.
[2] S. Solomon,et al. Predictors of Spontaneous Reverse Remodeling in Mild Heart Failure Patients With Left Ventricular Dysfunction , 2014, Circulation. Heart failure.
[3] Marco Merlo,et al. Long‐term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years , 2014, European journal of heart failure.
[4] M. Fertin,et al. Long-Term Functional and Clinical Follow-Up of Patients With Heart Failure With Recovered Left Ventricular Ejection Fraction After &bgr;-Blocker Therapy , 2014, Circulation. Heart failure.
[5] G. Barbati,et al. Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis , 2013, Circulation.
[6] M. Emdin,et al. Myocardial Fibrosis as a Key Determinant of Left Ventricular Remodeling in Idiopathic Dilated Cardiomyopathy: A Contrast-Enhanced Cardiovascular Magnetic Study , 2013, Circulation. Cardiovascular imaging.
[7] J. Daubert,et al. Resolution of left bundle branch block-induced cardiomyopathy by cardiac resynchronization therapy. , 2013, Journal of the American College of Cardiology.
[8] T. Sugiura,et al. Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy. , 2013, The American journal of cardiology.
[9] Shah Ebrahim,et al. [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)]. , 2013, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[10] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[11] K. Hirata,et al. Subclinical myocardial dysfunction in patients with reverse-remodeled dilated cardiomyopathy. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[12] G. Barbati,et al. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". , 2012, The American journal of cardiology.
[13] P. Binkley. A new Era in the natural history of dilated cardiomyopathy. , 2012, Journal of the American College of Cardiology.
[14] R. Cappato,et al. Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation. , 2011, American Journal of Cardiology.
[15] T. Kubo,et al. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy. , 2011, The American journal of cardiology.
[16] Marco Merlo,et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. , 2011, Journal of the American College of Cardiology.
[17] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[18] Renu Virmani,et al. A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .
[19] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[20] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[21] Journal of the American Heart Association The Genesis of Pulmonary Edema , 2005 .
[22] P. Poole‐Wilson,et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.
[23] R. Cappato,et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.
[24] M Gent,et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.
[25] L. Mestroni,et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. , 1999, European heart journal.
[26] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[27] G. Sinagra,et al. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. , 1997, Journal of the American College of Cardiology.
[28] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[29] G. Sinagra,et al. Changing mortality in dilated cardiomyopathy , 1994 .
[30] A. DeMaria,et al. Quantitative Assessment of Mitral Regurgitation by Doppler Color Flow Imaging: Angiographic and Hemodynamic Correlations , 1989, Journal of the American College of Cardiology.
[31] W. Edwards,et al. Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.
[32] J. Cohn,et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.